Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - Yew Bio-Pharm Group, Inc. | f8k110918_yewbiopharmgroup.htm |
Exhibit 16.1
November 15, 2018
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street NE Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of the Form 8-K for the event that occurred on November 9, 2018, of Yew Bio-Pharm Group, Inc. and are in agreement with the statements contained therein as much as they relate to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.
Very truly yours,
| /s/ MaloneBailey, LLP |
www.malonebailey.com
Houston, Texas